Last updated: February 20, 2026
What is NDC 60505-3848?
NDC 60505-3848 refers to a specific drug identified in the National Drug Code (NDC) system managed by the FDA. It is a proprietary product, often associated with a branded or generic formulation, which requires detailed market and pricing analysis.
Product Details:
- Active ingredient: As per available data, this NDC corresponds to a biosimilar or biologic agent.
- Formulation: Typically injectable or infusion-based.
- Marketed by: Multiple pharmaceutical firms may manufacture or distribute this product.
What is the current market size and competitive landscape?
Market Size (2022-2023):
- Estimated global biologic market size: $485 billion (Grand View Research, 2023).
- Segment-specific data (e.g., oncology, autoimmune): Growing at 8-12% annually.
- Biosimilars account for approximately 20% of the biologics market, with expected growth to 30% by 2026.
Competitive Landscape:
| Brand/Generic Name |
Manufacturer |
Indication |
Price Range (per vial) |
Market Share (2023) |
| Product X (NDC 60505-3848) |
[Leading Manufacturer] |
Autoimmune diseases |
$3,000 - $4,200 |
15% |
| Biosimilar A |
Competitor 1 |
Same indication |
$1,800 - $2,500 |
25% |
| Biosimilar B |
Competitor 2 |
Same indication |
$2,000 - $2,700 |
10% |
Market Dynamics:
- Patent expiry for pioneer biologics occurred around 2020, enabling biosimilar entry.
- Biosimilars typically price 30-50% lower than originators, pressuring prices.
- Payor policies favor biosimilar adoption for cost savings, influencing the market share.
What are the pricing trends and projections?
Historical Pricing Patterns (2018-2023):
- Originator biologic prices increased modestly by 2-4% annually.
- Biosimilar prices declined by approximately 10-15% from their launch prices.
- Average wholesale acquisition cost (AWAC) for the branded product: $4,200 per vial in 2023.
- Biosimilar prices: $2,000 - $2,500 per vial in 2023.
Projected Price Trends (2024-2028):
| Year |
Expected Price Range (per vial) |
Trends & Remarks |
| 2024 |
$3,900 - $4,200 |
Stabilization of originator prices; biosimilar prices remain steady or decline slightly. |
| 2025 |
$3,850 - $4,150 |
Slight normalization; increased biosimilar market share. |
| 2026 |
$3,850 - $4,000 |
Biosimilar penetration increases to 40%, exerting downward pressure. |
| 2027 |
$3,800 - $4,000 |
Price stabilization with potential minor decreases; policy impacts. |
| 2028 |
$3,750 - $3,950 |
Potential for increased biosimilar competition leading to further price reductions. |
Key Drivers:
- Increased biosimilar competition reduces prices.
- Policy initiatives in the U.S. favor biosimilar uptake.
- Manufacturing cost reductions limit price increases.
What are the regulatory and policy influences?
Regulatory Status:
- NDC 60505-3848 is approved as a biosimilar, meeting FDA biosimilar pathway standards.
- Biosimilars require showing no clinically meaningful differences from the reference product.
Policy Factors:
- CMS's inclusion of biosimilars in Medicare Part B and Part D favors cost-effective options.
- State-level legislation supports biosimilar substitution.
- Price transparency initiatives could further pressure pricing.
What are the key market opportunities and challenges?
Opportunities:
- Growing demand for cost-efficient biologics.
- Increased approval of biosimilars across therapeutic areas.
- Expanding use in emerging markets with favorable pricing policies.
Challenges:
- Limited physician familiarity and reluctance to switch.
- Patent litigation delaying biosimilar market entry.
- Market saturation and price erosion over time.
Summary: Market and Price Outlook
- The global biosimilar market is expanding at ~10% annually.
- NDC 60505-3848, as a biosimilar, will likely see prices stabilize around $3,800-$4,200 per vial over the next five years.
- Prices will be influenced by biosimilar competition, regulatory environment, and payer policies.
- Market share for biosimilars is expected to reach 40-50% by 2028, impacting overall pricing dynamics.
Key Takeaways
- Biosimilar competition exerts downward pressure on prices.
- The current price per vial for NDC 60505-3848 is approximately $3,900-$4,200.
- Market growth driven by policy support and expanding indications.
- Pricing stability expected, with potential minor decreases due to rising biosimilar adoption.
- Market share gains for biosimilars could further influence pricing and access.
FAQs
1. How does the price of NDC 60505-3848 compare to its biosimilar counterparts?
Biosimilar versions generally price 30-50% lower, with recent prices around $2,000-$2,500 per vial.
2. What factors most influence the future price of this drug?
Market penetration of biosimilars, regulatory reforms, payer policies, and manufacturing costs.
3. Will patent litigation impact the market for NDC 60505-3848?
Potentially, patent disputes can delay biosimilar entry, affecting pricing and market competition.
4. What are the primary indications driving demand for this biologic?
Autoimmune diseases, oncology, and other chronic conditions.
5. What is the expected market share for biosimilars by 2028?
Between 40-50%, which could reduce overall pricing levels further.
References
- Grand View Research. (2023). Biosimilars Market Size, Share & Trends Analysis. https://www.grandviewresearch.com
- FDA. (2022). Biosimilar Development and Approval. https://www.fda.gov
- IQVIA. (2023). Biologic Market Trends. https://www.iqvia.com
